PNLIP and obesity due to melanocortin 4 receptor deficiency: Ellagic acid has been previously shown to counteract obesity via inhibiting adipogenesis, de novo lipogenesis, and pancreatic lipase activity, and/or enhancing catabolism of fatty acids, thus decreasing abdominal fat deposits and abdominal circumference [9,10,12].